Literature DB >> 17604521

Prevalence of chlamydia in patients attending gynecological clinics in south eastern Nigeria.

L E Okoror1, D E Agbonlahor, F I Esumeh, P I Umolu.   

Abstract

BACKGROUND: Chlamydia infections have been reported to cause silent infections in communities which becomes endemic and could remain unnoticed for a very long time. In most parts of Nigeria these organisms are not screened for, and hence relative information about frequencies of the organisms are sparse.
METHOD: Five hundred and sixty five blood samples and ten umbilical cord fluids were collected from various patients attending clinics in South Eastern Nigeria and were screened for Chlamydia Complement Fixing Antibody (CCFA). Endocervical swabs and urethral discharges or swabs were collected from patients whose serum was positive and were cultured into embryonic eggs which was later observed, harvested and stained using the Romanowsky-Giemsa staining techniques. The positive sera were further confirmed by distinguishing the species of Chlamydia using the monoclonal antibody spot test kit. RESULT: Of the five hundred and sixty five (565) samples collected only three hundred and forty were positive to CCFA, of which 141 were males and 204 females. From the cultured samples 230 were positive for Chlamydia trachomatis and 99 positive to Chlamydia pneumoniae. Statistical analysis using the student's t test at 95% confidence interval shows that there was no significant difference between the number of females and males that presented themselves for screening.
CONCLUSION: Proper screening of patients to include Chlamydia should be encouraged at all levels of medical diagnosis in the country so as to proffer treatment. Otherwise the infection will remain a "silent epidemic", as is the case currently.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604521      PMCID: PMC2366126          DOI: 10.5555/afhs.2007.7.1.18

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  11 in total

1.  Mechanism of C. trachomatis attachment to eukaryotic host cells.

Authors:  J P Zhang; R S Stephens
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

2.  A simple system for the assessment of trachoma and its complications.

Authors:  B Thylefors; C R Dawson; B R Jones; S K West; H R Taylor
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  Community-based action for the control of trachoma.

Authors:  F C Hollows
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec

4.  Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran.

Authors:  C Kuo; S Wang; B B Wentworth; J T Grayston
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

Review 5.  Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment.

Authors:  M Kauppinen; P Saikku
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

6.  Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore.

Authors:  Woon Puay Koh; Mark B Taylor; Kenneth Hughes; S K Chew; C W Fong; M C Phoon; K L Kang; Vincent T K Chow
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

7.  Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma.

Authors:  R W Peeling; R L Bailey; D J Conway; M J Holland; A E Campbell; O Jallow; H C Whittle; D C Mabey
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

Review 8.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

9.  Epidemiology of urogenital infections caused by Chlamydia trachomatis and outline of characteristic features of patients at risk.

Authors:  R Sessa; M A Latino; E M Magliano; R Nicosia; R Pustorino; I Santino; C Gordini; P Clerici; R Colombo; M Del Piano
Journal:  J Med Microbiol       Date:  1994-09       Impact factor: 2.472

10.  The morphology of Chlamydia pneumoniae.

Authors:  N Miyashita; Y Kanamoto; A Matsumoto
Journal:  J Med Microbiol       Date:  1993-06       Impact factor: 2.472

View more
  7 in total

1.  African Health Sciences. Editorial.

Authors:  Michael G Kawooya
Journal:  Afr Health Sci       Date:  2007-03       Impact factor: 0.927

2.  Prevalence of Chlamydia trachomatis infection among patients attending infertility and sexually transmitted diseases clinic (STD) in Kano, North Western Nigeria.

Authors:  E O Nwankwo; Magaji N Sadiq
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

3.  Genital chlamydia trachomatis infection among female undergraduate students of University of Port Harcourt, Nigeria.

Authors:  A Ugboma Henry Arinze; Nwagwu Victor Onyebuchi; Jeremiah Isreal
Journal:  Niger Med J       Date:  2014-01

4.  Prevalence of chlamydia among HIV positive and HIV negative patients in the Vhembe District as detected by real time PCR from urine samples.

Authors:  Tshepo Malesela Mafokwane; Amidou Samie
Journal:  BMC Res Notes       Date:  2016-02-16

5.  Genital Chlamydia trachomatis Infection among Women of Reproductive Age Attending the Gynecology Clinic of Hawassa University Referral Hospital, Southern Ethiopia.

Authors:  Endale Tadesse; Million Teshome; Anteneh Amsalu; Techalew Shimelis
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

6.  Evaluation of Cortez OneStep Chlamydia Rapicard™ Insta Test for the Detection of Chlamydia trachomatis in Pregnant Women at Mbare Polyclinic in Harare, Zimbabwe.

Authors:  Stephen Stephen; Chiwoneso Gwyneth Elizabeth Muchaneta-Kubara; Marshall Wesley Munjoma; Gibson Mandozana
Journal:  Int J MCH AIDS       Date:  2017

7.  Prevalence of chlamydia trachomatis infection among reproductive age women in sub Saharan Africa: a systematic review and meta-analysis.

Authors:  Siraj Hussen; Demelash Wachamo; Zemenu Yohannes; Endale Tadesse
Journal:  BMC Infect Dis       Date:  2018-11-26       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.